No Data
No Data
No Data
No Data
No Data
Express News | Jazz Pharmaceuticals PLC : Needham Raises Target Price to $222 From $220: Needham Raises Target Price to $222 From $220
Moomoo 24/7Apr 19 05:36 ET
Express News | Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
Moomoo 24/7Apr 17 16:15 ET
HER2+ Market to Accelerate Substantially by 2034, Predicts DelveInsight | Key Companies - Zymeworks, Jazz Pharmaceuticals, Ambrx, AnBogen Therapeutics, Enliven Therapeutics, Roche
New York, USA, April 17, 2024 (GLOBE NEWSWIRE) -- HER2+ Market to Accelerate Substantially by 2034, Predicts DelveInsight | Key Companies - Zymeworks, Jazz Pharmaceuticals, Ambrx, AnBogen Therapeutics, Enliven
GlobeNewswireApr 17 13:00 ET
“Weight loss elixir” welcomes benefits again! LY.US (LLY.US) tirzepatide achieved positive results in late-stage trials to treat sleep disorders
Lily.US (LLY.US) announced on Wednesday that its weight loss therapy tirzepatide has achieved major goals in two phase 3 trials targeting patients with obesity and obstructive sleep apnea (OSA).
Zhitong FinanceApr 17 08:50 ET
Eli Lilly Obesity Therapy Succeeds in Late-stage Trials for Sleep Disorder
Seeking AlphaApr 17 07:04 ET
Breaking Down Jazz Pharmaceuticals: 15 Analysts Share Their Views
Providing a diverse range of perspectives from bullish to bearish, 15 analysts have published ratings on Jazz Pharmaceuticals (NASDAQ:JAZZ) in the last three months.The table below summarizes their re
BenzingaApr 10 10:01 ET
No Data
No Data